Table 1.
Clinicopathological characteristics and sequencing results from primary tissue and plasma (ctDNA) samples obtained from 14 colorectal cancer patients. Bold text indicates detected mutations. WT: wild type
| Nr. | Age | Gender | Pathologic Stage | Tissue [WES] | ctDNA | |
|---|---|---|---|---|---|---|
| Column | DTBP | |||||
| T1 | 68 | M | 2 | WT | WT | WT |
| T2 | 62 | M | 2 | WT | WT | WT |
| T3 | 54 | M | 4 | BRAF (V600E) | WT | BRAF (V600E) |
| T4 | 62 | M | 3 | KRAS (G12V) | WT | WT |
| T5 | 42 | M | 4 | WT | KRAS (G13D) | KRAS (G13D) |
| T6 | 42 | M | 2 | WT | WT | KRAS (G13D) |
| T7 | 48 | F | 4 | KRAS (G12V) | WT | WT |
| T8 | 34 | F | 4 | BRAF (V600E) | WT | BRAF (V600E) |
| T9 | 40 | M | 3 | KRAS (G13D) | KRAS (G13D) | KRAS (G13D) |
| T10 | 65 | M | 4 | KRAS (G12D) | KRAS (G12D) | KRAS (G12D) |
| T11 | 64 | F | 2 | WT | WT | WT |
| T12 | 42 | M | 3 | WT | WT | KRAS (G12D) |
| T13 | 72 | F | 3 | KRAS (G13D) | KRAS (G13D) | KRAS (G13D) |
| T14 | 56 | M | 4 | WT | WT | WT |